(1R,4aS,10aR)-1,4a-Dimethyl-N-[(morpholin-4-yl)carbothio­yl]-7-(propan-2-yl)-1,2,3,4,4a,9,10,10a-octa­hydro­phenanthrene-1-carboxamide

In the title compound, C(25)H(36)N(2)O(2)S, the cyclo­hexane and morpholine rings adopt chair conformations. The cyclo­hexene and cyclo­hexane rings form a trans ring junction with the two methyl groups in axial positions. The N—H and C=O bonds in the urea group are anti to each other. The crystal s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Xiao-Ping, Wu, Yong, Song, Zhan-Qian, Shang, Shi-Bin
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2010
Materias:
Organic Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011422/
https://www.ncbi.nlm.nih.gov/pubmed/21589388
http://dx.doi.org/10.1107/S1600536810044569
Descripción
Sumario:In the title compound, C(25)H(36)N(2)O(2)S, the cyclo­hexane and morpholine rings adopt chair conformations. The cyclo­hexene and cyclo­hexane rings form a trans ring junction with the two methyl groups in axial positions. The N—H and C=O bonds in the urea group are anti to each other. The crystal structure is stabilized by inter­molecular N—H⋯O hydrogen bonds.

Ejemplares similares